Top Story

TearLab withdraws proposed public offering of common stock

February 10, 2016

TearLab has withdrawn its proposed public offering of common stock, according to a company press release.

Due to current market conditions, the company believes that it is not in the best interest of its stockholders to raise equity capital.


BLOG: Three reasons why Medicare is our best payer

February 10, 2016
The cover story in this issue of Ocular Surgery News addresses the phenomenon of physicians opting out of Medicare. While few in our profession have made this switch…
Meeting News Coverage

Speaker: Venture capital drives innovation in medical retina research

February 9, 2016
MIAMI — Robust investment by venture capitalists is making up for stagnant government funding for medical research, particularly in the ophthalmic and…
Breaking News

Senate proposes new safety requirements for reusable devices

February 9, 2016
The Senate Committee on Health, Education, Labor and Pensions today favorably reported a bill requiring manufacturers of reusable medical devices like duodenoscopes to…
Breaking News

Legislators ask for national surveillance of neurological illnesses

February 9, 2016
The Senate health committee today recommended the establishment of a national surveillance system for neurological diseases.The objective of the “Advancing…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »

Achieving Premium Results with Premium IOL Cataract Surgery: Managing Patients’ Expectations and Improving Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Presbyopic intraocular lenses (IOLs) appear to be making inroads in cataract surgeons’ practices. The counterpart to…
More »
Meeting News CoverageVideo

VIDEO: Surgeon gives update on uses for amniotic membrane

February 6, 2016
More »